Health & Pharm General

Bluechiip Limited (ASX:BCT) Successfully Completes Share Purchase Plan

🕔5/29/2023 3:58:06 PM

Bluechiip Limited (ASX:BCT) (FRA:1BL) is pleased to confirm the successful completion of its share purchase plan ("SPP") first announced on Friday, 5 May 2023, raising $727,500.

Read Full Article

VIDEO: Proteomics International Laboratories Limited (ASX:PIQ) MD Dr. Richard Lipscombe Talks about the PromarkerD Test and Agreement with Sonic Healthcare

🕔5/17/2023 9:48:29 PM

In this interview, Dr. Richard Lipscombe, Managing Director of Proteomics International Laboratories Limited (ASX:PIQ), talks about the agreement recently entered into with Sonic Healthcare (USA).

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Sonic Healthcare USA Signs Licence for PromarkerD in the US

🕔5/10/2023 11:41:30 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce it has signed an exclusive licence agreement with Sonic Healthcare USA, a Division of Sonic Healthcare Ltd.

Read Full Article

Bluechiip Limited (ASX:BCT) Raises $2.2M and Announces Share Purchase Plan

🕔5/5/2023 9:57:11 AM

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, today announced it has successfully raised $2.2 million via a placement to institutional, sophisticated and professional investors.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) World Endometriosis Congress - New Diagnostic Test Showcased

🕔5/5/2023 8:15:15 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce it will present its potential new blood test for endometriosis at the world's leading endometriosis conference.

Read Full Article

VIDEO: Apiam Animal Health Limited (ASX:AHX) Managing Director Dr. Chris Richards Speaks with ABN Newswire About 3rd Quarter Results

🕔5/4/2023 10:37:05 PM

Apiam Animal Health Limited (ASX:AHX) Managing Director Dr. Chris Richards outlines the Apiam brand and growing business, with veterinary practices joining the Apiam brand.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Diabetes Drug, Canagliflozin, Lowers PromarkerD Diabetic Kidney Disease Risk Prediction Scores

🕔5/3/2023 7:55:34 PM

Proteomics International Laboratories Ltd (ASX:PIQ) in collaboration with Janssen Research & Development have shown that treatment with Canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease.

Read Full Article